SQ-LIP-000004 · v1.0 (archived) · View current version →
Is lipedema underdiagnosed, and can screening tools help identify it?
Because obesity is commonly defined by BMI alone (which ignores fat distribution), lipedema is frequently missed when workup stops at an obesity diagnosis. Self-administered screening questionnaires achieve high classification accuracy in development cohorts and may raise clinical suspicion, but they are not diagnostic on their own.
Knowledge freshness = share of the 4 indexed evidence sources from the last 5 years (newest 2022, oldest 2020) . Low freshness flags an ageing evidence base — not that the answer is wrong.
Evidence over time
supporting contradicting refining / context Each dot is a study, placed by year and coloured by whether the linked claim supports or contradicts the answer. As the surveillance loop runs, claim revisions and new evidence will extend this timeline.
Choose a format (Vancouver default). Citing a version captures the evidence state on that date; this page shows the current version — see version history.
What changed in this version
Initial version (v1.0): 3 founding claims indexed from the lipedema pilot. The automated surveillance loop (new-article ingestion → supports / contradicts / refines) has not yet run.
Supporting claims
- SCR-LIP-000007 supporting
Because obesity is commonly defined by BMI alone (which disregards fat distribution), lipedema is frequently underdiagnosed when workup stops at an established obesity diagnosis; ~81% of lipedema patients are classified overweight/obese by BMI.
DOI:10.1177/02683555211002340 · Amato ACM, 2021 - SCR-LIP-000008 supporting
A self-administered lipedema screening questionnaire achieves a high probability of correct classification (~91%) between women with and without lipedema, supporting its use to raise clinical suspicion.
DOI:10.1590/1677-5449.200114 - SCR-LIP-000009 supporting
The Brazilian Portuguese lipedema symptoms questionnaire (QuASiL) was translated, culturally adapted and validated, showing high comprehension and symptom-intensity scores that correlate with limb volume by segmental bioimpedance.
DOI:10.1590/1677-5449.200049
Contradictory claims
- None indexed yet.
Major uncertainty
Screening tools were validated in small specialized-clinic samples against clinical diagnosis only, not against imaging or in primary care.
Version history
- SQ-LIP-000004 · v1.0 — 2026-05-30 — founding index (3 claims) · view this version
Key references
DOI:10.1177/02683555211002340 · DOI:10.1590/1677-5449.200114 · DOI:10.1590/1677-5449.200049